PPP3CA Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. Store at -20°C. Avoid freeze/thaw cycles.
Lead Time
Typically, we can ship your orders within 1-3 business days of receiving them. Delivery times may vary based on the purchase method or location. For specific delivery estimates, please contact your local distributor.
Synonyms
Alpha isoform formerly PPP2B antibody; Calcineurin A alpha antibody; Calcineurin A1 antibody; CalcineurinA antibody; Calmodulin dependent calcineurin A subunit alpha isoform antibody; Calmodulin-dependent calcineurin A subunit alpha isoform antibody; CALN antibody; CALNA 1 antibody; CALNA antibody; CALNA1 antibody; CAM PRP catalytic subunit antibody; CAM-PRP catalytic subunit antibody; CCN 1 antibody; CCN1 antibody; CNA 1 antibody; CNA alpha antibody; CNA antibody; CNA1 antibody; PP2BA_HUMAN antibody; PPP2B antibody; Ppp3ca antibody; Protein phosphatase 2B catalytic subunit antibody; Protein phosphatase 3 (formerly 2B) catalytic subunit alpha isoform antibody; Protein phosphatase 3 catalytic subunit alpha isoform PPP3CA antibody; Protein phosphatase 3 catalytic subunit alpha isozyme antibody; Serine/threonine protein phosphatase 2B catalytic subunit alpha isoform antibody; Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform antibody
Target Names
Uniprot No.

Target Background

Function
Calcineurin, also known as PPP3CA, is a calcium-dependent, calmodulin-stimulated protein phosphatase that plays a crucial role in mediating intracellular calcium signaling. It dephosphorylates a wide range of substrates, many of which contain a PxIxIT motif or a LxVP motif. Its diverse functions include:
  • Activation of phosphatase SSH1, leading to cofilin dephosphorylation in response to elevated calcium levels.
  • Dephosphorylation and activation of DNM1L, inducing its translocation to the mitochondrion following mitochondrial depolarization.
  • Dephosphorylation of heat shock protein HSPB1.
  • Dephosphorylation and activation of transcription factor NFATC1.
  • Regulation of NFAT-mediated transcription through dephosphorylation of NFAT and promoting its nuclear translocation in response to increased calcium levels.
  • Dephosphorylation and inactivation of transcription factor ELK1.
  • Dephosphorylation of DARPP32.
  • Potential dephosphorylation of CRTC2 at 'Ser-171', leading to CRTC2 dissociation from 14-3-3 proteins.
  • Dephosphorylation of transcription factor TFEB at 'Ser-211' after Coxsackievirus B3 infection, facilitating nuclear translocation.
Gene References Into Functions
  1. A short-linear interaction motif between residues 337-343 of AKAP79 is the sole PP2B-anchoring determinant, sustaining these diverse topologies. PMID: 28967377
  2. Mutations in the PPP3CA gene are associated with Severe Neurodevelopmental Disease with Seizures. PMID: 28942967
  3. A distinct C-terminal autoinhibitory four-residue sequence in CNAbeta1, (462)LAVP(465), competitively inhibits substrate dephosphorylation. In vitro and cell-based assays revealed that the CNAbeta1-containing holoenzyme, CNbeta1, is autoinhibited at a single site by either of two inhibitory regions, CBD and LAVP, which block substrate access to the substrate-binding groove. PMID: 28842480
  4. Studies highlight the importance of the AKAP79/PP2B/protein kinase A complex's role in synaptic long-term depression in the CA1 region of the hippocampus. PMID: 27911714
  5. The Ca(2+)/calcineurin (CaN)/nuclear factor of activated T-cells (NFAT) c4 axis is required for neuritin-induced Kv4.2 transcriptional expression and potentiation of IA densities in cerebellum granule neurons. PMID: 27307045
  6. CN-A and nephrin were significantly reduced in the kidneys of a 10-year-old boy with relapsing steroid-resistant nephrotic syndrome. PMID: 27009276
  7. KIF1Bbeta influences mitochondrial dynamics through calcineurin-dependent dephosphorylation of Dynamin-related protein 1 (DRP1), causing mitochondrial fission and apoptosis. PMID: 26812016
  8. In Aspergillus fumigatus, activation of macrophage calcineurin-NFAT occurs through a phagosomal TLR9-dependent and Bruton's tyrosine kinase-dependent signaling pathway that is independent of MyD88. PMID: 25637383
  9. Data indicate that both nuclear factors of activated T cells (NFATs) motifs partially compete for binding but do not fully displace each other on the calcineurin (Cn) epitope. PMID: 24954618
  10. Lysosomal calcium signaling regulates autophagy through calcineurin and TFEB. PMID: 25720963
  11. Human herpesvirus 6B U54 binds the calcineurin (CaN) phosphatase enzyme, causing improper dephosphorylation and nuclear translocation of NFAT (nuclear factor of activated T cells) proteins, resulting in suboptimal IL-2 gene transcription. PMID: 25122797
  12. KSR2 deficiency affects stromal interaction molecule 1 (STIM1)/ORAI1 puncta formation, which is correlated with cytoskeleton disorganization. PMID: 24672054
  13. These findings support the novel mechanistic hypothesis that oxidation-induced global and/or local conformational changes within calcineurin. PMID: 25286016
  14. PKCepsilon may negatively regulate adverse myocardial remodeling by cooperating with calcineurin to downregulate fibrosis and induce transcription of cardioprotective wound healing genes, including COX-2. PMID: 24298017
  15. Mutations on the hydrophobic face of Calcineurin distal helix disrupt the structure gained upon CaM binding. PMID: 24191726
  16. Bile-induced NF-kappaB activation and acinar cell injury are mediated by calcineurin. PMID: 23744075
  17. Dephosphorylation of Aly1 by calcineurin serves as a regulatory switch to promote Aly1-mediated trafficking to the vacuole. PMID: 23824189
  18. Lower expression of PPP3CA and PPP3CB genes in atrium myocardium may be related to expressed postinfarction LV remodeling. PMID: 23888774
  19. PPP3CA down-regulation is associated with hepatocellular carcinoma infected with hepatitis C virus. PMID: 23317196
  20. Findings suggest that CaMKII and calcineurin provide a switch-like mechanism that controls Ca-dependent LIMK1, SSH1L and cofilin activation, and subsequently actin cytoskeletal reorganization. PMID: 22270398
  21. Data indicate that downregulation of hemoxygenase-1 expression in neutrophils from hypertensive subjects is likely mediated by CN, which acts by hindering translocation to the nucleus of the transcription factor NRF2. PMID: 22739212
  22. Alterations in calcineurin signaling in the caudate nucleus contribute to the pathogenesis of schizophrenia. PMID: 22285318
  23. NHE1 directly binds to calcineurin A and activates downstream NFAT signaling, leading to cardiomyocyte hypertrophy. PMID: 22688515
  24. The calcineurin crystal of trypsin-resistant catalytic domain belonged to the orthorhombic space group P2(1)2(1)2, with unit-cell parameters a = 161.6, b = 87.4, c = 112.0 A. PMID: 22691791
  25. Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathway. PMID: 22164265
  26. While an association of the polymorphisms rs2850328 and rs2395 and breast cancer was not detected in our case-control study population, other variants within the PPP3CA and MARK4 genes may still be associated with breast cancer. PMID: 22506312
  27. A protein encoded by this locus was found to be differentially expressed in postmortem brains from patients with atypical frontotemporal lobar degeneration. PMID: 22360420
  28. The authors demonstrate that the regulatory domain within calcineurin is unstructured and that it folds upon binding calmodulin, ousting the autoinhibitory domain from the catalytic site. PMID: 22100452
  29. High calcineurin A alpha protein is associated with bone metastasis in small-cell lung cancer. PMID: 21785830
  30. The C allele of protein phosphatase 3 subunit alpha rs3804358 polymorphism was overrepresented in athletes compared with controls, whereas the T allele of protein phosphatase 3 subunit beta rs3763679 polymorphism was underrepresented in athletes. PMID: 21233773
  31. Findings demonstrate that CaN functions as a critical signaling molecule during Th cell activation, regulating Bcl-10 phosphorylation and NF-kappaB activation. PMID: 21674474
  32. Calcineurin plays a significant role in the heart and in cardiac disease. PMID: 19879877
  33. Two new complementary roles for calcineurin in the regulation of the early UPR (Unfolded Protein Responses) have been identified. PMID: 20700529
  34. Data underscore the importance of the calcineurin gene in the molecular mechanisms of addiction and Alzheimer's diseases. PMID: 20590401
  35. CN mediates the Ang II-induced aldosterone synthesis through up-regulation of the CYP11B2 transcription. PMID: 20413672
  36. Data show that in patients with CHF, calpain upregulation was associated with an increase in cleavage of cain/cabin1 and the activation of CaN. PMID: 20514436
  37. Data suggest an association between polymorphisms in PPP3CA, PPP3R1 and PPP3R2 and baseline levels or trainability of endurance phenotype traits. PMID: 20107831
  38. PP2B is an important target of the aberrant acinar cell Ca(2+) rise associated with pathological protease activation and pancreatitis. PMID: 20501444
  39. Observational study and genome-wide association study of gene-disease association and gene-environment interaction. (HuGE Navigator) PMID: 20379146
  40. CnAalpha was significantly overexpressed in lung cancer tissues with bone metastasis as compared to tumors with non-bone metastases. PMID: 20422345
  41. The functional differences conferred upon CaN by the alpha or beta catalytic subunit isoforms suggest that the alpha:beta and CaN:substrate ratios may determine the levels of CaN phosphatase activity toward specific substrates. PMID: 12135494
  42. PKA and PPP2B are involved in the regulation of NF-kappaB in human monocytes. PMID: 12586544
  43. A 13-amino acid region within CN is essential for its interaction with NFAT and with two other CN-binding proteins, AKAP79 and Cabin-1. PMID: 15671033
  44. The activation of calcineurin by calpain I in the brain of patients with Alzheimer's disease has been reported. PMID: 16150694
  45. These results indicate that calcineurin mediates acetylcholinesterase expression during apoptosis. PMID: 17320203
  46. Activation of calcineurin is required for lytic granule exocytosis, but it is not the sole Ca2+-dependent step. PMID: 17478429
  47. Analysis of the secondary structure of the calcineurin regulatory region and the conformational change induced by calcium/calmodulin binding. PMID: 18296442
  48. CHP2 plays a role in tumorigenesis and as an activator of the calcineurin/NFAT signaling pathway. PMID: 18815128
  49. The study demonstrates that all CaN isoforms exhibit the same cytoplasmic subcellular distribution and are expressed in each tested cell line. Differences in substrate specificities may determine specific physiological functions of the distinct isoforms. PMID: 19154138
  50. A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants. PMID: 19285944

Show More

Hide All

Database Links

HGNC: 9314

OMIM: 114105

KEGG: hsa:5530

STRING: 9606.ENSP00000378323

UniGene: Hs.435512

Protein Families
PPP phosphatase family, PP-2B subfamily
Subcellular Location
Cytoplasm. Cell membrane; Peripheral membrane protein. Cell membrane, sarcolemma. Cytoplasm, myofibril, sarcomere, Z line. Cell projection, dendritic spine.
Tissue Specificity
Expressed in keratinocytes (at protein level).

Q&A

What is PPP3CA and why is it important in biological research?

PPP3CA represents the catalytic subunit of calcineurin, functioning as the only serine/threonine protein phosphatase regulated by Ca2+/calmodulin signaling pathways . This enzyme plays a crucial role in coupling calcium signals to cellular responses, making it a significant player in numerous physiological processes . In muscle tissue, PPP3CA is particularly important for differentiation processes and fiber type conversion, responding to mechanical loading and various signaling inputs . Additionally, PPP3CA participates in bone formation regulation through its effects on osteoblast differentiation .

The protein has a calculated molecular weight of 59 kDa, which corresponds to its observed molecular weight in experimental contexts . Its fundamental role in calcium-dependent signaling makes it a valuable target for researchers investigating cellular signaling mechanisms, muscle physiology, bone development, and related pathological conditions.

What applications are commonly supported by commercial PPP3CA antibodies?

Commercial PPP3CA antibodies support multiple experimental applications across various research methodologies. The primary applications include:

ApplicationTypical Dilution RangesNotes
Western Blot (WB)1:500-1:8000Frequently validated in neural, muscle, and cancer cell lines
Immunoprecipitation (IP)0.5-4.0 μg for 1.0-3.0 mg protein lysateSuccessfully tested in mouse brain tissue
Immunohistochemistry (IHC)1:50-1:500Validated in both normal tissues and cancer samples
Immunofluorescence (IF/ICC)1:50-1:500Particularly effective in neuronal cell lines
Flow Cytometry (FC)0.25 μg per 10^6 cellsValidated for intracellular staining in HeLa cells

When selecting an application, researchers should consider that PPP3CA antibodies have been extensively validated in Western blot analyses, with published applications confirming their utility in this methodology . Immunofluorescence applications have also been documented in peer-reviewed literature, though less extensively than Western blotting . It is recommended that researchers titrate these antibodies in their specific experimental systems to achieve optimal results.

What species reactivity can be expected from PPP3CA antibodies?

Commercial PPP3CA antibodies demonstrate reactivity across multiple species, though the exact reactivity profile varies between products. The following reactivity patterns have been experimentally confirmed:

Antibody SourceConfirmed ReactivityPredicted Reactivity
Proteintech (13422-1-AP)Human, MouseNot specified
Proteintech (55147-1-AP)Human, MouseNot specified
Affinity Biosciences (DF6208)Human, Mouse, RatPig, Bovine, Rabbit, Dog

The cross-species reactivity stems from the high conservation of PPP3CA protein sequences across mammalian species . Published studies have employed these antibodies in human, mouse, pig, monkey, and chicken samples . When working with species not explicitly listed as confirmed, researchers should conduct preliminary validation experiments to verify cross-reactivity, particularly focusing on the epitope region's sequence conservation.

What are the optimal storage and handling conditions for PPP3CA antibodies?

To maintain antibody performance and stability, appropriate storage and handling protocols are essential. PPP3CA antibodies are typically supplied in a liquid form containing PBS buffer with 0.02% sodium azide and 50% glycerol at pH 7.3 . This formulation helps maintain protein stability and prevent microbial contamination.

When using the antibody, avoid repeated freeze-thaw cycles, which can lead to protein denaturation and reduced performance. Allow the antibody to reach room temperature before opening the vial to prevent condensation, which could promote microbial growth or dilute the antibody solution.

How can I optimize Western blot protocols for PPP3CA detection in different tissue samples?

Optimizing Western blot protocols for PPP3CA detection requires careful consideration of tissue-specific factors. PPP3CA expression varies significantly between tissues, with particularly high expression in brain, skeletal muscle, heart, and certain cancer cell lines .

Tissue-Specific Extraction Considerations:
For neural tissues, use a buffer containing phosphatase inhibitors to preserve the native phosphorylation state of PPP3CA. In muscle tissues, employ mechanical disruption methods (homogenization) followed by detergent-based lysis to effectively solubilize membrane-associated PPP3CA. Tissue-specific extraction protocols are particularly important as PPP3CA has been successfully detected in mouse brain, skeletal muscle, heart, and pancreas tissues .

Loading Control Selection:
When analyzing tissue samples with variable PPP3CA expression, select loading controls appropriate for the tissue type. For neural tissues, consider synaptophysin or PSD-95; for muscle tissues, consider using alpha-actinin or tropomyosin.

Dilution Optimization:
Start with a mid-range dilution (1:1000) and adjust based on signal intensity. For tissues with high PPP3CA expression (brain, skeletal muscle), use higher dilutions (up to 1:8000) to prevent signal saturation . For tissues with lower expression (e.g., pancreas), use more concentrated antibody solutions (1:500) .

Membrane Transfer Parameters:
For optimal transfer of the 59 kDa PPP3CA protein, use a semi-dry transfer system with 20% methanol transfer buffer for 60-90 minutes. Alternatively, wet transfer can be performed at 30V overnight at 4°C to ensure complete protein transfer without heat-induced degradation.

Detection Enhancement Strategies:
For tissues with lower PPP3CA expression, consider using high-sensitivity ECL substrates or fluorescent secondary antibodies for detection. Signal amplification systems can be employed when working with limiting tissue samples.

What methodological approaches help distinguish between PPP3CA isoforms and family members?

Distinguishing PPP3CA from other protein phosphatase family members requires careful methodological consideration due to sequence homology and structural similarities. The following approaches have proven effective:

Antibody Selection Strategies:
Select antibodies raised against unique epitopes in PPP3CA that are not conserved in other family members. For instance, the Proteintech antibody (55147-1-AP) is specifically designed to target PPP3CA-specific epitopes, minimizing cross-reactivity with other phosphatase isoforms .

Immunoprecipitation Validation:
Perform immunoprecipitation followed by mass spectrometry to confirm antibody specificity. This approach has been validated for PPP3CA detection in mouse brain tissue , providing high-confidence identification even in complex protein mixtures.

Isoform-Specific PCR Controls:
When analyzing protein expression, perform parallel qRT-PCR to quantify isoform-specific mRNA levels, providing a complementary validation method for antibody-based detection. Design primers spanning unique exon junctions to ensure isoform specificity.

Knockout/Knockdown Verification:
Use genetic models (knockout mice or siRNA knockdown) as negative controls to verify antibody specificity. The absence or reduction of signal in these models confirms the antibody's specificity for PPP3CA.

Two-Dimensional Gel Electrophoresis:
Employ 2D-PAGE followed by Western blotting to separate PPP3CA from other phosphatases based on both molecular weight and isoelectric point, providing enhanced resolution compared to standard SDS-PAGE.

How should I troubleshoot inconsistent immunofluorescence results with PPP3CA antibodies?

Immunofluorescence (IF) applications with PPP3CA antibodies can present challenges due to variability in subcellular localization, expression levels, and technical factors. The following troubleshooting approach addresses common issues:

Fixation Method Optimization:
PPP3CA detection can be influenced by fixation methods. Compare paraformaldehyde (4%, 10-15 minutes) versus methanol fixation (100%, 10 minutes at -20°C) to determine optimal epitope preservation. For neuronal cells like SH-SY5Y, where PPP3CA antibodies have been successfully used in IF applications, paraformaldehyde fixation often yields superior results .

Permeabilization Protocol Refinement:
Test different permeabilization reagents (0.1-0.5% Triton X-100, 0.1% saponin, or 0.05% Tween-20) and durations (5-15 minutes) to optimize intracellular antigen accessibility while preserving cellular morphology. Excessive permeabilization can disrupt cellular structures, while insufficient permeabilization limits antibody access.

Blocking Strategy Enhancement:
Implement a dual blocking approach using 5% normal serum from the secondary antibody host species combined with 3% BSA to reduce both specific and non-specific background binding. Extended blocking (2 hours at room temperature or overnight at 4°C) can significantly improve signal-to-noise ratios.

Antibody Concentration Titration:
Perform a systematic dilution series ranging from 1:50 to 1:500 to identify the optimal antibody concentration . Test these dilutions across different cell types, as optimal concentrations may vary between cell lines due to differences in PPP3CA expression levels.

Antigen Retrieval Evaluation:
For tissues or fixed cell lines with potential epitope masking, compare heat-induced epitope retrieval methods using citrate buffer (pH 6.0) versus TE buffer (pH 9.0), as both have been successfully employed with PPP3CA antibodies in immunohistochemistry applications .

Cell Type-Specific Controls:
Include positive control cell lines with known PPP3CA expression, such as SH-SY5Y neuroblastoma cells, which have been validated for PPP3CA immunofluorescence detection .

How can researchers effectively validate the specificity of PPP3CA antibodies in experimental systems?

Rigorous validation of antibody specificity is critical for generating reliable research outcomes. The following multi-faceted approach ensures comprehensive validation:

Molecular Weight Verification:
Confirm that the detected protein band appears at the expected molecular weight (59 kDa for PPP3CA) . Multiple bands or significant deviation from the expected size may indicate cross-reactivity or protein degradation.

Peptide Competition Assay:
Pre-incubate the antibody with excess immunizing peptide before application to samples. Specific signal should be significantly reduced or eliminated, while non-specific binding will remain unaffected.

Multiple Antibody Comparison:
Test multiple antibodies targeting different epitopes of PPP3CA (e.g., Proteintech 13422-1-AP and 55147-1-AP) and compare detection patterns . Consistent results across antibodies significantly increase confidence in specificity.

Genetic Manipulation Controls:
Implement CRISPR/Cas9 knockout, siRNA knockdown, or overexpression systems to create samples with altered PPP3CA levels. Antibody signal should correspondingly decrease or increase, providing functional validation of specificity.

Mass Spectrometry Correlation:
Following immunoprecipitation with the PPP3CA antibody, perform mass spectrometry analysis to confirm the identity of the precipitated protein. This approach provides high-confidence validation of antibody specificity and has been successfully applied to PPP3CA detection in mouse brain tissue .

Tissue Expression Pattern Analysis:
Compare antibody staining patterns with known tissue expression profiles of PPP3CA. For instance, strong signals should be observed in brain, skeletal muscle, and heart tissues where PPP3CA is highly expressed .

What considerations are important when studying PPP3CA in different calcium signaling contexts?

PPP3CA's function is intimately connected to calcium signaling pathways, which introduces specific experimental considerations:

Calcium Chelation Controls:
Include experimental conditions with calcium chelators (EGTA or BAPTA-AM) to establish calcium-dependent PPP3CA activity baselines. This approach helps distinguish between calcium-dependent and calcium-independent phosphatase activities.

Calmodulin Interaction Analysis:
When studying PPP3CA function, consider co-immunoprecipitation experiments to assess calmodulin binding under various calcium concentrations, as this interaction is critical for PPP3CA activation and function in coupling calcium signals to cellular responses .

Subcellular Fractionation Approaches:
Implement subcellular fractionation to investigate compartment-specific PPP3CA distribution, as its localization may shift between cytoplasmic and nuclear compartments depending on calcium signaling states. This is particularly relevant when studying PPP3CA's role in transcriptional regulation.

Physiological Calcium Concentration Ranges:
Design experiments with calcium concentrations that reflect physiological ranges (100 nM to 1 μM for resting cells, up to 10 μM for stimulated cells) to accurately model in vivo PPP3CA regulation.

Calcium Signaling Pathway Crosstalk:
When investigating PPP3CA in specific pathways, consider potential crosstalk with other calcium-regulated systems. For instance, in muscle differentiation studies, assess interactions between PPP3CA-mediated signaling and calcium-dependent protein kinase pathways, as PPP3CA plays an important role in muscle fiber type conversion .

What protocols maximize immunoprecipitation efficiency for PPP3CA interaction studies?

Efficient immunoprecipitation (IP) of PPP3CA is essential for studying protein-protein interactions and post-translational modifications. The following protocol has been optimized based on successful PPP3CA IP experiments in mouse brain tissue :

Optimized Lysis Buffer Composition:
Use a lysis buffer containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, with freshly added protease inhibitors and phosphatase inhibitors. For calcium-sensitive interactions, include 1 mM CaCl₂ or 2 mM EGTA to study calcium-dependent and calcium-independent interactions, respectively.

Antibody Quantity Optimization:
Use 0.5-4.0 μg of PPP3CA antibody per 1.0-3.0 mg of total protein lysate . This ratio provides an optimal balance between specific binding and background. For co-immunoprecipitation applications, the higher end of this range may be preferable to capture transient or weak interactions.

Pre-Clearing Strategy:
Implement a pre-clearing step using protein A/G beads and non-immune IgG from the same species as the primary antibody to reduce non-specific binding. Incubate lysate with pre-clearing beads for 1 hour at 4°C before the primary antibody incubation step.

Extended Incubation Parameters:
For maximum capture efficiency, incubate the antibody-lysate mixture overnight at 4°C with gentle rotation. This extended incubation enhances binding of low-abundance complexes and weakly interacting partners.

Washing Stringency Gradient:
Employ a gradient washing approach with decreasing salt concentrations (starting with high stringency and moving to lower stringency) to remove non-specific binding while preserving specific interactions. Typically, three washes with decreasing NaCl concentrations (500 mM, 250 mM, 150 mM) are effective.

Elution Techniques for Downstream Applications:
For mass spectrometry applications, elute with 0.1 M glycine (pH 2.5) followed by immediate neutralization. For Western blot analysis, elution with standard SDS sample buffer at 95°C for 5 minutes is sufficient.

How should I optimize antigen retrieval for PPP3CA detection in different tissue types?

Effective antigen retrieval is critical for successful PPP3CA detection in fixed tissues. The following optimization strategies address tissue-specific challenges:

Buffer Selection Based on Tissue Type:
For epithelial tissues and cancer samples (such as colon and cervical cancer), TE buffer (pH 9.0) has demonstrated superior results and is recommended as the primary antigen retrieval solution for PPP3CA detection . For tissues with high collagen content, citrate buffer (pH 6.0) can serve as an alternative method .

Optimization Matrix Approach:
Implement a systematic matrix approach testing different combinations of:

  • Buffer types (citrate pH 6.0 vs. TE pH 9.0)

  • Heating methods (microwave vs. pressure cooker vs. water bath)

  • Duration (10-30 minutes)

  • Temperature (90-120°C)

Tissue-Specific Protocol Modifications:
For highly fixed tissues (such as archival samples), extend retrieval time by 5-10 minutes beyond standard protocols. For delicate tissues prone to disintegration, reduce retrieval intensity by lowering temperature and extending duration.

Combined Enzymatic and Heat-Induced Retrieval:
For challenging tissues, consider a sequential approach using protease K digestion (5-15 μg/ml, 10 minutes at 37°C) followed by heat-induced retrieval at reduced intensity. This combined approach can be particularly effective for heavily cross-linked samples.

Validation Using Multiple Detection Methods:
After optimizing antigen retrieval for immunohistochemistry, validate findings using alternative detection methods such as RNA in situ hybridization or adjacent section Western blotting to confirm specificity and sensitivity of the protocol.

What quantification methods are most reliable for PPP3CA expression analysis?

Accurate quantification of PPP3CA expression is essential for comparative studies. The following approaches provide reliable quantification strategies:

Western Blot Densitometry Standards:
For Western blot quantification, use recombinant PPP3CA protein standards to generate a calibration curve spanning 0.1-10 ng, enabling absolute quantification. Include these standards on each blot to account for inter-blot variability. Normalize target signals to appropriate loading controls based on tissue type and experimental conditions.

Multiplexed Fluorescent Western Blotting:
Employ two-color fluorescent Western blotting with simultaneous detection of PPP3CA and loading controls to improve quantification accuracy. This approach eliminates stripping and reprobing steps that can introduce variability. Use fluorophores with well-separated emission spectra to avoid channel bleed-through.

RT-qPCR Reference Gene Selection:
When quantifying PPP3CA mRNA levels, select reference genes based on tissue-specific expression stability. For neuronal samples, consider ACTB and GAPDH; for muscle tissues, use RPLP0 and B2M as reference genes. Always validate reference gene stability under your experimental conditions before proceeding with relative quantification.

Immunohistochemistry Quantification Parameters:
For quantitative immunohistochemistry, employ digital image analysis with the following parameters:

  • Color deconvolution to separate DAB staining from hematoxylin

  • Nuclear vs. cytoplasmic compartmentalization

  • H-score calculation combining intensity and percentage of positive cells

  • Automated region-of-interest selection based on tissue morphology

Absolute Protein Quantification via Mass Spectrometry:
For highest accuracy, implement targeted mass spectrometry approaches using isotope-labeled peptide standards derived from unique regions of PPP3CA. This approach enables absolute quantification independent of antibody binding efficiency variations.

How can PPP3CA antibodies be effectively utilized in studying muscle fiber type conversion?

PPP3CA plays a critical role in muscle fiber type conversion through calcium signaling pathways . The following methodological approach maximizes research outcomes in this area:

Fiber Type-Specific Co-Localization Protocol:
Implement dual immunofluorescence staining combining PPP3CA antibodies (1:100 dilution) with fiber type-specific markers: myosin heavy chain I (type I fibers), myosin heavy chain IIa (type IIa fibers), and myosin heavy chain IIb (type IIb fibers). This approach enables direct correlation between PPP3CA expression levels and specific fiber types.

Functional Activity Correlation:
Pair PPP3CA protein detection with calcineurin phosphatase activity assays to correlate expression levels with enzymatic function. This is particularly important as PPP3CA's role in muscle differentiation depends on its phosphatase activity regulated by calcium/calmodulin binding .

Exercise and Loading Model Selection:
When studying PPP3CA's response to mechanical loading, select appropriate models based on research questions:

  • For endurance adaptations: treadmill running protocols (10-12 weeks)

  • For resistance adaptations: functional overload models

  • For electrical stimulation patterns: low-frequency for slow-twitch conversion, high-frequency for fast-twitch conversion

Temporal Profiling Strategy:
Implement a time-course analysis of PPP3CA expression following exercise or loading interventions, sampling at multiple timepoints (0h, 3h, 6h, 12h, 24h, 48h, 1wk) to capture both acute and chronic adaptation phases. This temporal profile helps distinguish between transient signaling events and persistent adaptations in muscle fiber phenotype.

Subcellular Distribution Analysis:
Assess PPP3CA nuclear translocation in response to calcium signaling events using subcellular fractionation followed by Western blotting or high-resolution confocal microscopy. Nuclear localization of PPP3CA correlates with activation of NFAT transcription factors that regulate fiber type-specific gene expression programs.

What considerations are important when using PPP3CA antibodies in neuronal research models?

Neuronal systems present unique challenges and opportunities for PPP3CA research due to the protein's critical role in calcium-dependent signaling pathways. The following methodological considerations enhance research outcomes:

Neuronal Subtype Selectivity Analysis:
PPP3CA expression and function can vary between neuronal subtypes. When working with mixed neuronal cultures or brain tissue sections, combine PPP3CA immunostaining with markers for specific neuronal populations (e.g., CaMKII for excitatory neurons, GAD67 for inhibitory neurons) to identify cell type-specific expression patterns.

Dendritic Spine Localization Protocol:
For high-resolution studies of PPP3CA in synaptic compartments, implement super-resolution microscopy techniques (STED or STORM) with carefully optimized fixation protocols to preserve dendritic spine morphology. PPP3CA antibodies have been successfully used for immunofluorescence in neuronal cell lines like SH-SY5Y , but spine-specific localization requires enhanced resolution approaches.

Activity-Dependent Regulation Studies:
Design experiments to capture activity-dependent changes in PPP3CA distribution and function:

  • Before stimulation: baseline localization and phosphatase activity

  • During stimulation: acute translocation and activation

  • After stimulation: persistence or reversal of changes

Synaptic Fractionation Approach:
When analyzing PPP3CA distribution in neuronal compartments, employ synaptic fractionation protocols to isolate presynaptic, postsynaptic, and extrasynaptic fractions. This approach enables quantitative assessment of PPP3CA enrichment in specific neuronal compartments and has been validated for PPP3CA detection in mouse brain tissue .

Calcium Imaging Integration: Combine PPP3CA immunocytochemistry with prior calcium imaging in living neurons to correlate calcium transient patterns with subsequent PPP3CA localization or activation. This integrative approach connects functional calcium signaling to molecular cascades regulated by PPP3CA.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.